Femasys Inc
FEMY0.809USD
-0.011-1.32%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
21.91MCap. mercado
PérdidaP/E TTM
Más Datos de Femasys Inc Compañía
Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.
Información de la empresa
Símbolo de cotizaciónFEMY
Nombre de la empresaFemasys Inc
Fecha de salida a bolsaJun 18, 2021
Director ejecutivoMs. Kathy Lee-Sepsick
Número de empleados69
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 18
Dirección3950 Johns Creek Court
CiudadSUWANEE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal30024
Teléfono17705003910
Sitio Webhttps://www.femasys.com/
Símbolo de cotizaciónFEMY
Fecha de salida a bolsaJun 18, 2021
Director ejecutivoMs. Kathy Lee-Sepsick
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
384.31K
+9.80%
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
5.67K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
80.00
--
Mr. Dov Elefant
Mr. Dov Elefant
Chief Financial Officer
Chief Financial Officer
--
--
Dr. James Liu, M.D.
Dr. James Liu, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Independent Director
Independent Director
--
--
Mr. Daniel Currie
Mr. Daniel Currie
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Edward Uzialko, Jr.
Mr. Edward Uzialko, Jr.
Independent Director
Independent Director
--
--
Ms. Christine Thomas
Ms. Christine Thomas
Chief Regulatory and Clinical Officer
Chief Regulatory and Clinical Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
384.31K
+9.80%
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
5.67K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
80.00
--
Mr. Dov Elefant
Mr. Dov Elefant
Chief Financial Officer
Chief Financial Officer
--
--
Dr. James Liu, M.D.
Dr. James Liu, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Desglose de ingresos
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
341.26K
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 18 de jul
Actualizado: vie., 18 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Chernett (Jorey)
4.99%
Dauntless Investment Group, LLC
4.84%
Uzialko (Edward R Jr.)
3.74%
The Vanguard Group, Inc.
2.54%
CM Management, LLC
1.31%
Other
82.58%
Accionistas
Accionistas
Proporción
Chernett (Jorey)
4.99%
Dauntless Investment Group, LLC
4.84%
Uzialko (Edward R Jr.)
3.74%
The Vanguard Group, Inc.
2.54%
CM Management, LLC
1.31%
Other
82.58%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
10.52%
Investment Advisor
10.24%
Investment Advisor/Hedge Fund
1.26%
Hedge Fund
0.23%
Venture Capital
0.10%
Research Firm
0.09%
Bank and Trust
0.05%
Other
77.52%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
70
7.31M
22.48%
+821.23K
2025Q1
67
7.22M
24.70%
+706.34K
2024Q4
60
4.03M
17.61%
-312.38K
2024Q3
58
3.32M
14.71%
-994.98K
2024Q2
60
3.27M
14.50%
-951.60K
2024Q1
59
3.16M
17.88%
-1.13M
2023Q4
59
3.12M
17.80%
-765.84K
2023Q3
57
3.89M
25.74%
+6.18K
2023Q2
54
3.49M
25.26%
-520.59K
2023Q1
51
3.40M
28.73%
-4.68M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Chernett (Jorey)
1.62M
4.99%
+1.62M
--
Feb 19, 2025
Dauntless Investment Group, LLC
1.58M
4.84%
+145.30K
+10.16%
Mar 31, 2025
Uzialko (Edward R Jr.)
1.22M
3.74%
--
--
Apr 08, 2025
The Vanguard Group, Inc.
825.67K
2.54%
--
--
Mar 31, 2025
CM Management, LLC
425.00K
1.31%
--
--
Mar 31, 2025
Lee-Sepsick (Kathy)
384.31K
1.18%
+34.31K
+9.80%
Jun 02, 2025
Clear Creek Financial Management, LLC
270.37K
0.83%
+14.00K
+5.46%
Mar 31, 2025
Geode Capital Management, L.L.C.
245.51K
0.75%
+29.34K
+13.57%
Mar 31, 2025
Currie (Daniel Scott)
109.24K
0.34%
+19.61K
+21.88%
Jun 02, 2025
State Street Global Advisors (US)
56.37K
0.17%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
